Monthly chemistry ortho clinical diagnostics testing for medical treatment facility

Ended Awarded Last action

Contract number
HT009026FJ027
Awardee
Awarding agency
Obligated
$43,138

Award facts

Contract value 100% obligated
$43,137.84 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Raritan, NJ 08869, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a BPA call to Ortho-Clinical Diagnostics, Inc., a HUBZone joint venture, for monthly chemistry ortho clinical diagnostics testing at a ceiling value of $43,137.84, with award date May 21, 2026. The source does not name the parent BPA. Performance occurs in Raritan, New Jersey, with ultimate completion September 30, 2026. The call covers supply of monthly chemistry ortho clinical diagnostics testing for medical treatment facility operations under firm fixed pricing. No set-aside was applied.

Quick answers

Who was awarded contract HT009026FJ027?

HT009026FJ027 was awarded to Ortho-Clinical Diagnostics, Inc. by Defense Health Agency (Department of Defense) on May 21, 2026.

How much is contract HT009026FJ027 worth?

The government has obligated $43,138 on HT009026FJ027.

Is contract HT009026FJ027 an order under another contract?

Yes. HT009026FJ027 is a BPA call under FA860122A0002, a blanket purchase agreement.

Was contract HT009026FJ027 competed?

The extent of competition for HT009026FJ027 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award